Mira Sirotic
Director of Investor Relations for Maxwell Biosciences
Mira Sirotic is the Director of Investor Relations & Investor of Maxwell Biosciences, a preclinical stage drug platform company founded in 2016 that is actively developing a net biotechnology platform that creates low molecular weight compounds that are similar to peptides and at the same time distinct from macromolecules and can easily penetrate membranes.
She strongly believes in values-based servant leadership and in sharing & developing resources, experiences, and relationships that are focused on enriching the lives of all people in order to build better communities and organizations.
Mira Sirotic is a Certified Management Accountant (CMA) with 20+ years of experience covering investment relationships, business expansion, market & communications, and others.
She’s also an Investor Member of Keiretsu Forum, a global investment community of highly skilled angel investors, venture capitalists, and corporate and institutional investors. Founded in 2000 and headquartered in San Francisco, California, Keiretsu Forum became a worldwide network of capital resources, investing in high-quality investment opportunities.
Mira’s roles include:
- Director at Investor Relations & Investor of Maxwell Biosciences: https://maxwellbiosciences.com/
- LinkedIn: https://www.linkedin.com/company/maxwell-biosciences/
- Investor Member at Keiretsu Forum: https://www.keiretsuforum.com/
- LinkedIn: https://www.linkedin.com/company/keiretsu-forum/
- Mira’s LinkedIn: https://www.linkedin.com/in/mirasiroticcma/?originalSubdomain=ca
- Mira’s Crunchbase: https://www.crunchbase.com/person/mira-sirotic
Mira’s goal is to help people and organizations reach their maximum potential and improve themselves. She strives to connect to people with the platforms and partners that will help them achieve success and inspire them to create lasting relationships.
Mira Sirotic is a member of the Global Investment Leaders Club: “As far as this group goes, one of the things you can gain from GILC is the fact that you’re going to connect with a very strong network of people who will bring you a quality deal flow and companies that hopefully will operate beyond the norms of mainstream. Because of our connections and for myself, as someone who is still part of the deal screening committee within my investor ecosystem, I look for a broad range of sectors to introduce you to other contacts as much as I can. Some folks talked here about logistics, construction, real estate, technology, life sciences, so all of these sectors are of interest to me and while Maxwell is in BioTech, and we fuel the future pharma development, that’s just one hat that I wear. So, I think you will find that folks within the ecosystem of the Global Investment Leaders Club are great connectors.”